{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:13:06Z","timestamp":1759335186317},"reference-count":7,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T00:00:00Z","timestamp":1079395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim\u2002<\/jats:bold> To study the efficacy, safety, and compliance of 500\u00a0mg azithromycin thrice weekly for 12\u00a0weeks in acne vulgaris.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> An open\u2010label, noncomparative study was carried out for 12\u00a0weeks at the outpatient clinics of Aga Khan University Hospital, Abassi Shaheed Hospital, and Burhani Community Hospital in Karachi, Pakistan. Thirty\u2010five adolescent and postadolescent patients with moderate to severe papulopustular acne vulgaris were enrolled. All patients completed the study. Azithromycin, 500\u00a0mg orally thrice weekly for 12\u00a0weeks, was used. After the baseline visit, patients were scheduled to return at four\u2010weekly intervals for 12\u00a0weeks. Efficacy was gauged by the percentage clearance of papulopustular acne lesions. Safety assessments included the monitoring of adverse events, and compliance was checked at the four\u2010weekly regular visits up to 12\u00a0weeks.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Twenty\u2010nine patients (82.9%) showed remarkable improvement in the first 4\u00a0weeks with 60% reduction of their inflammatory papulopustular lesions. Maximum clearance (80%) was observed at 12\u00a0weeks. Residual postinflammatory pigmentation and pitted and linear scarring represented the aftermath of the relapsing pattern of acne. Six patients (17.1%) showed slow clearance with eruptions of new lesions. Adverse events, such as heartburn and nausea, were reported by four patients (11.4%). All patients completed the 12\u2010week study period.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Azithromycin, 500\u00a0mg thrice weekly for 12\u00a0weeks, is a safe and effective treatment of acne vulgaris with excellent patient compliance.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2004.02058.x","type":"journal-article","created":{"date-parts":[[2004,10,7]],"date-time":"2004-10-07T15:13:47Z","timestamp":1097162027000},"page":"766-767","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Acne treated successfully with azithromycin"],"prefix":"10.1111","volume":"43","author":[{"given":"Naseema","family":"Kapadia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu","family":"Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,6]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"5","article-title":"Beauty creams causing acneiform eruptions","volume":"11","author":"Kapadia N","year":"2000","journal-title":"J Pakistan Assoc Dermatologist"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00749.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1254\/fpj.117.343"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.11.1710"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90395-E"},{"key":"e_1_2_5_7_2","first-page":"1944","volume-title":"Physicians\u2019 Desk Reference","year":"1996"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13339.x"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2004.02058.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2004.02058.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T08:53:11Z","timestamp":1696927991000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2004.02058.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,6]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-4632.2004.02058.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2004.02058.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,6]]},"assertion":[{"value":"2004-04-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}